REVEAL: Randomized EValuation of the Effects of Anacetrapib Through Lipid-modification

This study is currently recruiting participants.
Verified November 2013 by University of Oxford
Sponsor:
Collaborator:
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
University of Oxford
ClinicalTrials.gov Identifier:
NCT01252953
First received: November 24, 2010
Last updated: November 12, 2013
Last verified: November 2013